China Has Deployed Operational Hypersonic Weapons While the U.S. Has Zero Fielded

As of early 2024, China has fielded the DF-17 medium-range ballistic missile with a hypersonic glide vehicle, deployed to operational PLA Rocket Force brigades. Russia has deployed the Avangard HGV on modified SS-19 ICBMs and the Kinzhal air-launched ballistic missile (which Russia classifies as hypersonic). The United States, despite spending over $15 billion on hypersonic development since 2018, has zero operationally deployed hypersonic weapons. The LRHW (Long Range Hypersonic Weapon) for the Army has been delayed to 2025-2026. The Navy's CPS is not expected until 2028+. The Air Force scaled back ARRW and is pursuing HACM, which won't be operational until the late 2020s. This deployment gap matters because hypersonic weapons are specifically designed for time-sensitive, high-value targets — mobile missile launchers, command posts, carrier groups. The side that deploys first gains a coercive advantage: they can threaten targets the other side cannot defend, while the other side cannot respond in kind. China's DF-17, deployed across the Taiwan Strait, can hold U.S. and allied bases in Japan and Guam at risk with a weapon that current missile defenses cannot reliably intercept. The U.S. has no equivalent capability to hold Chinese targets at similar risk. The implication for a Taiwan contingency is acute. If China can suppress U.S. forward bases with hypersonic strikes in the opening hours of a conflict, the U.S. ability to project power into the Western Pacific is degraded before conventional forces can respond. This isn't about who has the 'better' weapon — it's about who has a weapon at all when the shooting starts. The problem persists because the U.S. hypersonic programs have been caught in a cycle of test failures, requirement changes, and bureaucratic restructuring. The ARRW program failed three consecutive flight tests, was scaled back, then partially revived. The LRHW has experienced manufacturing delays with its common glide body. Each program is managed by a different military service with different requirements, timelines, and contractors, resulting in duplicated effort and fragmented investment. There is no single 'hypersonic czar' with authority and budget control across the enterprise. Structurally, the U.S. fell behind because it deprioritized hypersonic weapons after the Cold War, treating them as a technology-push research area rather than an operational urgency. China and Russia, by contrast, invested aggressively in hypersonics starting in the 2000s specifically to circumvent U.S. missile defenses. By the time the Pentagon recognized the competitive gap (around 2018), China had a 10-15 year head start in flight testing and manufacturing scale-up.